Max Herzberg

Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel.

Sepal Pharma SA develops cancer therapies. The company was founded on July 20, 2004 and is headquartered in Paris, France.

Part of The European Molecular Biology Laboratory, EMBL Enterprise Management Technology Transfer GmbH is an alternative investment manager. The company is based in Heidelberg, Germany. The German company was founded in 1999. The CEO is Gabor M. Lamm.

Pixcell Medical Technologies Ltd. develops, produces, and markets portable medical diagnostic products for point of care testing. Its product is HemoScreen. The company was founded by Max Herzberg and Avishay Bransky on June 3, 2008 and is headquartered in Yokneam Ilit, Israel.

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

FertiSeeds Ltd. develops technology for producing high yield hybrid seeds. It focuses on development of unique, state-of-the-art technologies with wide global applications and on speedy commercialization. The company was founded by Max Herzberg and Shamay Izhar in 2000 and is headquartered in Ness Ziona, Israel.

BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel.